L & S Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,594
| Closed | -$1.76M | – | 367 |
|
|
2024
Q1 | $1.76M | Sell |
13,594
-798
| -6% | -$103K | 0.2% | 134 |
|
|
2023
Q4 | $1.39M | Buy |
14,392
+98
| +0.7% | +$9.45K | 0.17% | 135 |
|
|
2023
Q3 | $1.73M | Buy |
14,294
+3,880
| +37% | +$470K | 0.25% | 103 |
|
|
2023
Q2 | $1.19M | Buy |
10,414
+3,099
| +42% | +$355K | 0.16% | 135 |
|
|
2023
Q1 | $1.01M | Sell |
7,315
-2,829
| -28% | -$390K | 0.14% | 150 |
|
|
2022
Q4 | $1.31M | Sell |
10,144
-1,363
| -12% | -$177K | 0.24% | 101 |
|
|
2022
Q3 | $1.27M | Buy |
+11,507
| New | +$1.27M | 0.22% | 102 |
|
|
2021
Q1 | – | Sell |
-17,751
| Closed | -$3.03M | – | 391 |
|
|
2020
Q4 | $3.03M | Buy |
17,751
+7,995
| +82% | +$1.36M | 0.35% | 93 |
|
|
2020
Q3 | $1.37M | Sell |
9,756
-1,770
| -15% | -$249K | 0.19% | 158 |
|
|
2020
Q2 | $1.85M | Sell |
11,526
-784
| -6% | -$126K | 0.28% | 97 |
|
|
2020
Q1 | $1.2M | Sell |
12,310
-1,493
| -11% | -$146K | 0.23% | 103 |
|
|
2019
Q4 | $1.78M | Sell |
13,803
-105
| -0.8% | -$13.5K | 0.23% | 101 |
|
|
2019
Q3 | $1.05M | Buy |
13,908
+1,125
| +9% | +$84.8K | 0.15% | 170 |
|
|
2019
Q2 | $1.94M | Sell |
12,783
-610
| -5% | -$92.7K | 0.26% | 108 |
|
|
2019
Q1 | $1.6M | Buy |
13,393
+455
| +4% | +$54.2K | 0.21% | 110 |
|
|
2018
Q4 | $1.41M | Buy |
12,938
+825
| +7% | +$90K | 0.27% | 75 |
|
|
2018
Q3 | $1.96M | Buy |
12,113
+398
| +3% | +$64.3K | 0.25% | 93 |
|
|
2018
Q2 | $1.55M | Sell |
11,715
-98
| -0.8% | -$13K | 0.26% | 97 |
|
|
2018
Q1 | $875K | Buy |
11,813
+3,278
| +38% | +$243K | 0.17% | 133 |
|
|
2017
Q4 | $475K | Buy |
+8,535
| New | +$475K | 0.07% | 185 |
|